i s o l a t e d from i n f e c t e d I V catheters produce a l o o s e l y adherent slime m a t e r i a l , which we have p r e v i o u s l y demonstrated i n t e rf e r e s w i t h human PMN chemotaxis. A surface I~l , i~~~J t~s j s assay was used t o c l o s e l y simulate c a t h e t e r i n f e c t i o n s ; slime e f f e c t s on chemiluminescence (CL) and superoxide (02-) productjon were examined.
Human PMN were added t o l a y e r s o f S. epi incubated 18 hours on p l a s t i c p l a t e s . Control S. epi were washed t o remove slime and adhered t o p l a s t i c p l a t e s f o r 2 hours. JH-labeled b a c t e r i a were present a t approximately 1 0 : l bacteria/PMN r a t i o . A t 15 and 60 minutes PMN phagocytosis o f S. epi w i t h slime was l e s s than t h a t o f washed S. epi (p<.05). Opsonization (10% human sera) d i d n o t s i g n i f i c a n t l y increase uptake o f S. epi w i t h slime i n c o n t r a s t t o washed b a c t e r i a (7% versus 42% change). P u r i f i e d S. epi slime modestly decreased PMN CL and 0 -production i n response t o zymosan and phorbol myrista?e acetate.
Sl ime stimulated PMN s p e c i f i c granule release ( l a c t o f e r r i n ) .
S. epi slime i n h i b i t i o n o f PMN chemotaxis, phagocytosis and o x i d a t i v e metabolic response may c o n t r i b u t e t o t h e persistence o f these b a c t e r i a on p l a s t i c catheters.
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TION PRESENTING AS RECURRENT ASEPTIC MENINGITIS. Anand G. Kantak, P a t r i c k G. Brosnan, Tasnee -----Chonmaitree, Tamara A. Rakusan, james F, Jones, and Armond S. Goldman. The University of Texas Medical Branch, Department of P e d i a t r i c s , Galveston, and t h e National Jewish Hospital, Denver.
A wide spectrum of chronic-reactivation i n f e c t i o n s due t o EBV has been documented i n p a t i e n t s with o r without primary immunod e f i c i e n c i e s .
Recently, we found evidence suggesting EBV a s t h e cause of r e c u r r e n t a s e p t i c meningitis. This male c h i l d presented s e v e r a l y e a r s beforehand with r e c u r r e n t u r t i c a r i a , a r t h r a l g i a s , chronic p a p i l l i t i s , neurosensory hearing l o s s , and 5 episodes of a s e p t i c meningitis ( l a s t episode a t 13.2 yr.).
CSF during a c u t e episodes contained up t o 1x10' leukocytes/mm3 ( p r i n c i p a l l y n e u t r o p h i l s ) , elevated p r o t e i n s (70-250mg/dl), but no microorganisms. B and T c e l l functions appeared normal. Serum a n t i antigen. Thus, t h e chronic-recuri-ent c e n t r a l nervous system abn o r m a l i t i e s may be due t o EBV. EBV genes and a n t i g e n s i n t h e c h i l d ' s c e l l s and immune response of t h e p a t i e n t t o EBV a r e being i n v e s t i g a t e d .
source-of v i r b s -i n most cases o f neonatal herpes, m o n i t o r i n q i n t h e l a s t t r i m e s t e r f o r q e n i t a l v i r u s i n a woman w i t h a h i s t o r y i n h e r s e l f o r her partner i s c u r r e n t l y recomnended as a method o f possible prevention by C-section. W e have examined the prevalence o f a h i s t o r y o f q e n i t a l herpes, as well as measured VSV-2 antibodies ( w i t h an imunodot ELISA on n i t r o c e l l u l o s e paper usina a p u r i f i e d HSV-2 t y p e s p e c i f i c qlycoprotein, q6-2) i n two o b s t e t r i c ~o p u l a t i o n s : a low socioeconomic (LS) qrouo o f 300 women and a middle class HMO aroup o f 187 women. The prevalence o f q e n i t a l herpes i n preqnant women by h i s t o r y i n LS was 1 . 5 h n d i n HMO 10%; i n c l u d i n q a h i s t o r y o f g e n i t a l herpes i n the male partner, t h e r a t e s were 4% and 13% r e s p e c t i v e l y . The r a t e s of HSV-2 antibodies i n the preqnant women were 49% (LS) and 332 (HMO). V a r i a b i l i t y i n h i s t o r y and antibody r a t e s was noted accordinq t o age, race and awareness o f t h e c l i n i c a l e n t i t y o f q e n i t a l herpes. W e conclude: (a) t h a t a h i q h proportion o f o b s t e t r i c p a t i e n t s are a t some r i s k f o r t r a n s m i t t i n q HSV t o t h e i r i n f a n t s ; (b) t h e c u r r e n t monitoring p o l i c y needs t o be modified.
The changinq patterns o f neonatal herpes as a consequence o f t h e above, as well as other current f i n d i n g s t o be discussed, w i l l a f f e c t any new approaches t o management o f t h i s severe neonatal orobl em. 
The m o r t a l i t y and m o r b i d i t y o f neonatal GBS disease remain s i g n i f i c a n t , even w i t h optimal a n t i b i o t i c therapy. ,Recently, w i t h t h e a v a i l a b i l i t y o f several ISG preparations m o d i f l e d f o r l v adm i n i s t r a t i o n . use o f t h i s m a t e r i a l as t h e r a~e u t i c a d j u n c t has been suggested. However, i t i s n o t known whether ISG-modified by d i f f e r e n t methods w i l l have s i m i l a r b i o l o g i c a l a c t i v i t y . W e compared f u n c t i o n a l a c t i v i t i e s i n v i t r o and i n v i v o o f two ISG modif i e d f o r i v use against a t y p e m B S , r a u c e d a n d a l k y l a t e d (RA) and n a t i v e (N) 1SGs. Both preparations (5%
I n v i t r o s t u d i e s measured phagocytosis and k i l l i n g o f t h e GBS s t r a i n by r a t PMNs i n t h e presence o f ISG and r a t complement. E f f i c i e n t opsonophagocytosis (>go% k i l l i n g ) occurred w i t h d i l u t i o n o f RA ISG vs <10-'* a i l u t i o n o f N ISG. The f i n d i n g s suggest t h a t RA ISG i s l e s s a c t i v e than N ISG against type I 1 1 GBS. Further s t u d i e s a r e needed t o understand t h e mechanisms responsible f o r t h i s apparent discrepancy i n f u n c t i o n a l a c t i v i t y o f RA and N ISGs. i n t o one o f t h e h i b h -r i s k aroubs. I n f e c t i o n s w i t h EBV a r e
P e d i a t r i c s , Torrance, CA; UCSD School o f Medicine, Oept. o f Medicomnon i n these p a t i e n t s aGd a r e responsible f o r some o f t h e severe complications o f t h e disease. We have studied a c h i l d w i t h AIDS and h i s mother; both harbor EBV. We wished t o determine whether they were i n f e c t e d w i t h t h e same s t r a i n . W e examined c e l l u l a r DNA from lymphoblastoid c e l l l i n e s (LCL's) derived from t h e c h i l d and h i s mother f o r d i f f e r e n t EBV i s o l a t e s using Southern b l o t a n a l y s i s w i t h probes prepared from cloned segments o f t h e EBV genome. A LCL derived from lymph node biopsy t i s s u e and one from t h e p a t i e n t ' s peripheral blood contained two d i f f e r e n t genotypes o f EBV. A LCL t h a t arose spontaneously from mother's blood contained t h e same two EBV genotypes. A s i n g l e c e l l subclone o f t h e mother's LCL contained o n l y one o f these s t r a i n s ; thus t h e mother's LCL was shown t o be p o l y c l o n a l . A f t e r one year o f observation t h e i n f a n t developed a CNS lymphoma which was shown t o c o n t a i n y e t a t h i r d EBV genotype. These r e s u l t s i n d i c a t e t h a t , a t l e a s t i n AIDS p a t i e n t s , simultaneous i n f e c t i o n s w i t h more than one EBV s t r a i n i s possible. Whether t h i s i s a l s o t r u e o f immunocompetent hosts i s p r e s e n t l y unknown. These data a l s o r a i s e t h e p o s s i b i l i t y o f v e r t i c a l transmission o f EBV from mother t o i n f a n t . cine, San Diego; Walter Reed Army Medical Center, Washington, O.C. The m o r b i d i t y and m o r t a l i t y associated w i t h neonatal EC i n f e ct i o n have remained s i g n i f i c a n t despite advances i n a n t i m i c r o b i a l chemotherapy. I n a search f o r more effective therapy, we evaluated combination therapy against a K, EC w i t h cefotaxime (Ct) and two d i f f e r e n t antibody (Ab) preparations, r a b b i t 55 antiserum (55 Ab) and murine IgM monoclonal antibody t o t h e l i p o p o l y s a ccharide o f t h e i n f e c t i n g EC serotype (LPS Ab). EC bacteremia and m e n i n g i t i s were induced i n 5-day-old r a t s by sc ~n o c u l a t l o n . A t 6 days o f age, each l i t t e r was d i v i d e d i n t o 3 groups t o r e c e i v e Ct (50 mg/kg sc twice d a i l y ) , one o f the Ab preparations (50 ~1 / 10 gm i p ) o r combination therapy. A c o n t r o l r a t from each 1 i t t e r received s a l i n e . B a c t e r i a l .counts i n blood and CSF were determined d a i l y before and during therapy and mortality recorded. A l l animals r e c e i v i n g s a l i n e died. B a c t e r i a l clearance was i n v e r s e l y r e l a t e d t o t h e m o r t a l i t v , which i s summarized below:
55 Ab 10/10 (100%) LPS Ab 15/17 (88%) Ct+J5 Ab 7/11 ( 64%) CttLPS Ab 6/24 (25%) As noted, LPS Ab enhanced t h e e f f i c a c y o f Ct w h i l e J5 Ab was n o t b e n e f i c i a l . These f i n d i n g s suggest t h a t t h e combination o f a n t ib i o t i c s and LPS Ab have enhanced e f f i c a c y i n t h i s model.
